`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF TEXAS
`MARSHALL DIVISION
`
`ALLERGAN, INC.,
`
`Plaintiff,
`
`v.
`
`Civil Action No. 2:15-cv-1455-WCB LEAD
`Civil Action No. 2:15-cv-1504 WCB
`Civil Action No. 2:16-cv-0401 WCB
`
`TEVA PHARMACEUTICALS USA, INC.,
`ET AL.,
`
`
`
`CONSOLIDATED
`
` Defendants.
`
`ORDER OF DISMISSAL WITHOUT PREJUDICE
`
`Pursuant to Rule 41(a)(1)(A)(ii) of the Federal Rules of Civil Procedure, recognizing the
`
`Joint Stipulation of Dismissal filed by Plaintiff Allergan, Inc. (“Allergan”) and Defendant
`
`InnoPharma Inc. (“InnoPharma”) pursuant to settlement of the above-captioned litigation
`
`between the parties, it is ordered as follows:
`
`ORDERED that the claims asserted herein by Allergan against InnoPharma in the action
`
`be, and hereby are, dismissed without prejudice;
`
`ORDERED that the counterclaims and defenses asserted by InnoPharma against Allergan
`
`be, and hereby are, dismissed without prejudice; and
`
`ORDERED that the parties shall bear their own attorneys’ fees, expenses, and costs.
`
` IT IS SO ORDERED.
`
`SIGNED this 16th day of October, 2017.
`
`_____________________________
`WILLIAM C. BRYSON
`UNITED STATES CIRCUIT JUDGE
`
`